Latest News and Press Releases
Want to stay updated on the latest news?
-
Kuehn Law Encourages MORF, AMBC, INFN, and BEST Investors to Contact Law Firm
-
MORF REMINDER: Robbins LLP is Investigating the Officers and Directors of Morphic Holdings, Inc
-
Investors of Morphic Holdings, Inc. Should Contact Robbins LLP for Information About Our Investigation
-
Morphic Holding, Inc. Investors Should Contact Robbins LLP for Information About Our Investigation of MORF
-
WALTHAM, Mass., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious...
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Morphic Holding, Inc....
-
WALTHAM, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious...
-
-Reported positive topline results from EMERALD-1 study of MORF-057 in ulcerative colitis- -Continued enrollment on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis- -Greater...
-
WALTHAM, Mass., June 06, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious...
-
WALTHAM, Mass., May 05, 2023 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (“Morphic”), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic...